Aronora Is A Translational Biotechnology Companyaronorabio Comengaged In The Development Of Proprietary Biologic Therapeuticsincluding Recombinant Monolconal Antibodies And Enzymesrational Design Of Our Innovative Therapeutic Agents Is Expected To Result In Drug Products That Reduce The Progression And Growth Of Life Threatening Blood Clots Without The Detrimental Bleeding Side Effects That Characterize All Currently Marketed Antithrombotic Drugsour Products Are Intended To Be Used In Difficult To Treatsevererapidly Progressingor Catastrophic Thrombotic Blood Clotting Diseases
Bio International Convention 2025
United States
16 Jun 2025
2765
| Company Name | Aronora Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
